(b) family history of physical and psychiatric illness; (c) initial diagnosis and detailed psychiatric history prior to commencing lithium treatment, including age of onset, length and pattern of illness, previous treatment, characteristics of illness including the presence or absence of specific symptoms, frequency of relapses, suicide attempts.
Follow-up status
In 1971, the entire cohort of patients who had been taking lithium for up to 5 years was reviewed (Benaim & Lappin, 1973) . They were assigned to one of three outcome groups, depending on whether their response to lithium was complete, partial or insignificant. These outcome groups weredefined asfollows: (a) complete response, i.e. there had been no episodes of hypomania or depression requiring treatment whilst the patient was taking lithium; (b) partial response, i.e. some episodes of illnessoccurred whilst the patient was taking lithium, but these were less often and produced less handicap (in terms of need for additional medication, admission to hospital, duration of episode, time away from work) than those prior to lithium treatment; (c) insignificant response, i.e. there was no detectable change in frequency or severity of relapses after lithium treatment was begun. In 1983, attempts were made to trace these patients again via out-patient clinics, general practitioners, family
Method
The subjects were a consecutive series of 101 patients, the first to be treated with prophylactic lithium by one to functionadequatelyat workand at home.A comparison was then made with the pre-lithium data for each individual and with the data obtained in 1971, the latter to assess the stability of the response. These comparisons were analysed using the chi-squared test.
Resufts
Of the 101patients, 59 were interviewedin 1983:20 were dead (detailedinformationregardingthis group wassought from case notes, general practitioners and relatives),two werelivingabroad, four refused to be interviewedand 16
were never traced.
Characteristic of the Initial sample

Sociodemographic details
The originalgroup comprised47 men and 54women,their ages ranging from 19 to 75 years, the mean age at commencing lithium treatment being 45 years. A total of 74 were married, nine divorced, 15 single and three widowed.
According to the Registrar General's dassification, 22Â¾ were social class 1,49% social class II, 20Â¾social class III non manual, 7Â¾social class III manualand2Â¾social class IV.
Diagnosis
At the time of starting lithium, 35patients wereclassedby one of the authors (S. B.) as having unipolar affective disorder, 65 bipolar affective disorder and one a schizo affective disorder.
Family history of psychiatric illness
A positive family history of bipolar illness was found in 61 subjects,and in all but one of these, their own diagnosis wasalso that of bipolar illness.There wasa familyhistory of umpolar illness in 46, which was evenly distributed amongst subjects with both diagnoses. There was a family historyof completedsuicidein 18,of which14werebipolar subjects. Nine had a family history of alcoholism; all of these were bipolar subjects.
Age of onset of illness
36 and 45 years, and in 15 it was over 45 years. There was no significant difference in age of onset of illness between those subjects with bipolar and those with unipolar disorders.
Characteristics of illness prior to lithium
The characteristicsof illnessbefore treatment with lithium includedon average8.5 depressiveepisodes(range 0â€"80),
3.8 admissions for depression (range 0â€"30),2.7 hypo manicepisodes(range0-16), 2.1 admissionfor hypomania (range 0â€"9). The average frequency of episodes was 19
months.
The length of illness prior to lithium treatment varied from 1 month to 30 years, with a mean of 5 years. The frequency of occurrence of episodes was no different between unipolar and bipolar subjects.
Analysis of preliminary data
All the preliminary data were examined to see whether the original population could be defined by distinct subgroups, clustering in terms of sex, age of onset of illness, symptoms or family history. Using the chi-squared test to compare subgroups, it was not possibleto demonstrate any signifi cant clusters.
Follow-up data (1983)
Patients not available
No follow-up data were available for 22 patients. This group was not significantly different from the remainder of the original population intermsof any initial variables, as determined from their case notes.
Patients who had died
Twenty patients had died by 1983.The causes of death were: suicide (6), cancer (5), myocardial infarction (4), accident (2), cerebrovascularaccident(1), respiratoryfailure(1)and pulmonary embolus (1). At the time of death, eight of these were known to still be taking lithium. In comparing the 20 dead subjects with the rest of the original population, there was no major differentiating characteristic of statis tical significance. All six who committed suicide had been diagnosed as having bipolar illness, in each case charac tensed by severe depressions which prevented them from working or functioning socially;five had shown a partial responseto lithium and one had shown no response. The average age at time of death was 47 years (range 30â€"56).
Patients who were interviewed
A total of 59 patients were re-interviewed in 1983. On examination of their mental state, including use of the PSE, none of these were found to have clinically significant psychiatric signs or symptoms, either at the time of interview or in the preceding 4 weeks. It was therefore presumed that the data which they provided at those interviews were valid.
Lithium usage
Their average age at starting lithium was 45 years (range 19â€"75) . Figure 1 shows the length of time for which these patients had regularlytaken lithium; most had taken it for more than 13 years.
In 30, the age of onset of illness was less than 25 years, in 34 it was between 26 and 35 years, in 22 it was between 10Â¾ an insignificantresponse. In the 12years sincethese patients had been reviewed, the proportions in each group had not changed and there was no movement between outcome groups of the 59 patients followed up in 1983.
Having categorised the patients in terms of their response to lithium, all the preliminary and follow-up data were examined to see whether there were any variables which correlated with outcome (using the chi-squared test). No association was found between outcome and any of the variables examined, which included: age, sex, family history, age of onset of illness, diagnosis, previous treatment, previous physical history, nature and severity of their pre-lithium illness, dose of lithium, average serum level and concurrent treatment or side-effects.
During the period of lithiumtreatment, the marital and socioeconomic status of these patients had remained similar to that pre-lithium, but a higher proportion were able to work fulltime (36 compared with 12 before lithium).
At the sametimeof follow-up,four subjectswerefound to be living in institutions (one in a long-stay ward of a psychiatric hospital, three in old people's homes).
Other treatment
Additional treatment was givenconcurrentlyto 43 (73Â¾)
of these patients at some point during their lithium treatment. In the case of patients who had no further episodes of affective illness after starting lithium, the additional treatment given was either hypnotic drugs or psychotherapy. The percentages receiving other forms of treatment,comparedwiththe pre-lithiumfigures,are shown in Table I .
Side-effects
The side-effectsrecordedin the case notes, or reported on detailed questioning at interview of the 59 patients, were as follows:tremor (23subjects),subjectivememoryloss(23), weight gain (21), polyuria or polydipsia (21), loss of creati vity (11), diarrhoea (10), hypothyroidism(10), goitre (7), nausea (5), impotence (5), gastric pain (4)and psoriasis(4). Hypothyroidism was diagnosed biochemically by routine measurement of plasma T3 and 14 and of TSH. Eleven subjects stopped taking lithium because of side-effects.
None of the 59 patients seenin 1983had any known renal disease and no other side-effects which might be specifically associated with prolonged use of lithium were detected. well, without medication, for over 6 years.
Outcome
As described above, the subjects were all assigned to one of three outcome groups, both in 1971and in 1983. (1976a) found no association between negative family history and failure of lithium prophy laxis. In addition, on analysis of the relationship between sex, age at treatment, diagnosis, number of previous episodes, age of onset of illness and outcome of treatment, they concluded that there was no significant association between any of these factors and outcome. Our long-term study substan tiated this evidence and also demonstrated no correlation between eventual outcome and certain other factors, including previous physical history, previous treatment, severity of illness before treatment, symptoms before treatment, dose, serum level and occurrence of side-effects.
Fourthly, only three of our subjects could be defined as â€˜¿ rapid cyclers' (four or more affective episodes per year), and all of these seemed to derive considerable benefit from prophylactic lithium. Dunner & Fieve (1974) described this subgroup of manic-depressive patients and noted that they seemed not to respond to prophylactic lithium.
However, in a later paper, Dunner et a! (l976b)
re-analysed the data from their sample of â€˜¿ rapid cyclers' and concluded that lithium carbonate was effective in preventing hypomanic episodes in these patients. Fifthly, the mean serum level, measured 12 h post dose, was 0.7 mmol/litre in all three outcome groups, with no correlation between mean serum level and outcome. The guidelines concerning desirable plasma lithium levels for prophylaxis are still conflicting. A number of studies have indicated a higher rate of relapse among subgroups of patients maintained with average serum levels below 0.4 mmol/litre (Hullin, 1980) and 0.8 mmol/litre (Pnien & Caffey, 1976 woman stopped lithium in order to become pregnant; she became hypomanic after the birth, and lithium treatment was re-instituted. There were no reports of infertility amongst these subjects, although their age and illness meant that most were not wishing to have more children. The wives of four of the male subjects became pregnant; there were no reports of physical or psychological problems in these children.
Discussion
This study presents retrospective data from a large cohort of patients taking prophylactic lithium over a period of up to 17 years. Potential bias was introduced, in that 22 patients were either not traced or would not be interviewed. It is possible that these subjects were those in whom lithium had not produced a favourable response, and that they were therefore unwiffing to cooperate with the study. This group of patients is also unusual in the marked bias towards social classes I and II, which is thought to be due to the inclusion of patients referred from outside London and even from other countries, at a time when lithium was not widely used or available. These latter patients were predominantly from the higher social classes.
Despite these methodological shortcomings, the results obtained do reveal several interesting points. First, 50Â°lo of patients showed a complete remission whilst on prophylactic lithium, 40% showed a partial but significant response and 10% a negligible response. This response was true of both unipolar and bipolar patients, and the prophylactic effect of lithium carbonate did not diminish with time in the patients who showed a good response. The percentage of patients who show no apparent response to prophylactic lithium varies considerably in published studies. However, all studies agree that there is a significant proportion of both unipolar and bipolar patients who will relapse whilst taking lithium carbonate. This study has followed subjects over a long period of time, and has indicated that the subjects can be categorised according to response within the first 5 years of treatment. On examining the same subjects 12 years later, none had moved from one outcome group to another. It has previously been suggested by Dunner & Fieve (1974) that if patients are followed for long enough, they will all ultimately have a further affective episode, but this study did not confirm that hypothesis.
Secondly, in the bipolar group of patients, lithium was equally effective in preventing hypomanic and depressive episodes. This has been a subject of debate for some years, since Pnen et a! (1971, l973a,b, 1974) found that lithium had a greater effect in preventing LONG-TERM STUDY OF PROPHYLACTIC LITHIUM CARBONATE against depression is ineffective. Sashidaran et a! (1982) followed a cohort of 53 patients on lithium therapy and retrospectively detailed their serum level and mental state over a period of 3 years. They found that those who did not relapse during the trial had spent significantly less time with serum levels over 0.9 mmoVlitre than had those who relapsed. Finally, the side-effects found in our subjects have all been previously well documented. There was a surprisingly high incidence of clinical hypothy roidism, and further work is in progress to examine this group in more detail. We were not able to demonstrate any side-effects specifically associated with long-term lithium treatment, but in view of the association of tardive dyskinesia and long-term neuroleptic treatment, it is essential to continue to monitor closely those patients who have taken lithium for extended periods, in case of similar developments.
